glp 1 drugs and alcohol consumption Weight Loss May Also Curb Substance Use Disorders IUPHAR review – Glucagon-like peptide-1

Description

Diabetes 66(4):868879

Across major trials: Lean mass typically represents 2540% of total weight lost , meaning 6075% is fat loss . Imaging studies suggest tirzepatide may improve muscle quality , reducing fat infiltration within muscle tissueeven as total lean mass declines. A prospective 12-month semaglutide study demonstrated favorable body-composition changes with preserved or improved functional outcomes in some participants. In short: body composition improves , even when the scale shows lean-mass reduction. Muscle Changes by Weight-Loss Method How to Preserve Muscle on Semaglutide or Tirzepatide Protein targets for GLP-1 patients A clinically supported target for preserving lean mass during weight loss is: 1.21.6 g/kg/day ( 0.540.73 g/lb/day ) for most adults Higher intakes approximately 0.71.0 g per pound of body weight per day may be beneficial for individuals performing regular resistance training, particularly during calorie restriction, to better preserve or increase lean mass. Distributing protein across meals (often ~2540 g per meal ) supports muscle protein synthesis. Resistance training 23 per week Resistance training provides the mechanical signal required to retain muscle.

It has recently been reported that human GLP-1 analogues were more effective in reducing the occurrence of major adverse cardiovascular events, myocardial infarctions, and hospitalizations due to cardiovascular causes when compared to exendin-based GLP-1RAs [71]

They also show interest in smaller servings, higher protein dishes, plant-based options and meals perceived as lighter

7476 Evidence suggests that PKA-dependent protection of GLP-1 is mediated through enhanced ATF4-CHOP-growth arrest and DNA damage inducible gene 34 (GADD34) signaling, resulting in eukaryotic initiation factor 2 alpha dephosphorylation and translational recovery